Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Eukaryotic Promoter Region02:40

The Eukaryotic Promoter Region

18.9K
The eukaryotic promoter region is a segment of DNA located upstream of a gene. It contains an RNA polymerase binding site, a transcription start site, and several cis-regulatory sequences.  The proximal promoter region is located in the vicinity of the gene and has cis-regulatory sequences and the core promoter. The core promoter is the binding site for RNA polymerase and is usually located between -35 and +35 nucleotides from the transcription start site. The distal promoter regions are...
18.9K
The Eukaryotic Promoter Region02:40

The Eukaryotic Promoter Region

4.0K
4.0K
iPS Cell Differentiation01:22

iPS Cell Differentiation

3.1K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.1K
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

16.8K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
16.8K
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

3.5K
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
3.5K
Models of Health Promotion and Illness Prevention II01:18

Models of Health Promotion and Illness Prevention II

2.1K
The person's health status fluctuates continually, varying from being in good health to becoming ill and returning to being healthy. To understand the concept of illness prevention, there are two models. First, the health-illness continuum model is a graphic representation of an individual's wellness. It states that a person is considered healthy in the absence of physical disease and the presence of good emotional health.
The agent-host-environment model states that disease results...
2.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immunity: from specificity to physiological integration.

Nature reviews. Immunology·2026
Same author

ADAR1 deficiency in pancreatic cancer cells potentiates cDC1 activation and promotes sensitization to immunotherapy.

Cancer immunology research·2026
Same author

A unique CD4⁺ T cell subset expressing granzyme K is regulated by transcription factor EOMES and important for T cell-mediated intestinal inflammation.

Nature immunology·2026
Same author

Facile induction of immune tolerance by an interleukin-2-TGFβ surrogate agonist.

Nature·2026
Same author

A metabolic alarmin from keratinocytes potentiates systemic humoral immunity.

Nature·2026
Same author

The conserved noncoding sequence CNS11 is a master control region for <i>Rorc</i> transcription in type 17 immune cells.

Science advances·2026

Related Experiment Video

Updated: Feb 8, 2026

Measuring Mitochondrial Function of Na&#239;ve and Effector CD8 T Cells
06:07

Measuring Mitochondrial Function of Naïve and Effector CD8 T Cells

Published on: March 28, 2025

1.2K

Zbtb32 promotes CD8+ T cell differentiation and function in cancer.

Birui Pan1, Qinli Sun1, Ruifeng Li1

  • 1Institute for Immunology, Tsinghua University , Beijing, China.

The Journal of Experimental Medicine
|February 6, 2026
PubMed
Summary

Zbtb32 promotes the development of terminally exhausted CD8+ T cells (Ttex), enhancing their anti-tumor activity. This discovery offers new avenues for cancer immunotherapy by targeting Ttex cell function.

More Related Videos

Transient Treatment of Human Pluripotent Stem Cells with DMSO to Promote Differentiation
06:55

Transient Treatment of Human Pluripotent Stem Cells with DMSO to Promote Differentiation

Published on: July 17, 2019

15.4K
Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells
09:57

Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells

Published on: January 29, 2019

23.4K

Related Experiment Videos

Last Updated: Feb 8, 2026

Measuring Mitochondrial Function of Na&#239;ve and Effector CD8 T Cells
06:07

Measuring Mitochondrial Function of Naïve and Effector CD8 T Cells

Published on: March 28, 2025

1.2K
Transient Treatment of Human Pluripotent Stem Cells with DMSO to Promote Differentiation
06:55

Transient Treatment of Human Pluripotent Stem Cells with DMSO to Promote Differentiation

Published on: July 17, 2019

15.4K
Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells
09:57

Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells

Published on: January 29, 2019

23.4K

Area of Science:

  • Immunology
  • Cancer Biology
  • Molecular Biology

Background:

  • The tumor microenvironment contains exhausted CD8+ T cells, including progenitor (Tpex) and terminally exhausted (Ttex) subsets.
  • Tpex cells are regulated by Zbtb27/Bcl6 and can be reinvigorated by immune checkpoint blockade (ICB).
  • Ttex cells exhibit enhanced proliferation and cytotoxicity, crucial for tumor control, but their differentiation mechanisms are unclear.

Purpose of the Study:

  • To investigate the role of Zbtb32 in CD8+ T cell differentiation and function within the tumor microenvironment.
  • To elucidate the mechanisms by which Zbtb32 influences Ttex cell characteristics and anti-tumor capabilities.

Main Methods:

  • Analysis of Zbtb32 expression in CD8+ T cell subsets within tumors.
  • Investigating the regulation of Zbtb32 by CD28 signaling.
  • Studying the impact of Zbtb32 on Ttex cell differentiation, proliferation, cytotoxicity, and anti-tumor function.
  • Examining the competitive DNA binding between Zbtb32 and Bcl6, particularly concerning Id2 regulation.

Main Results:

  • Zbtb32 is highly expressed in CD8+ Ttex cells and is crucial for their function in tumors.
  • CD28 signaling regulates Zbtb32, which promotes Ttex differentiation, enhancing cytotoxicity and proliferation.
  • Zbtb32 and Bcl6 compete for DNA binding, influencing Id2 expression.
  • Zbtb32 significantly enhances CD8+ T cell anti-tumor capability.

Conclusions:

  • Zbtb32 plays a pivotal role in the anti-tumor function of CD8+ Ttex cells.
  • Zbtb32 acts as a key regulator of Ttex cell differentiation and function.
  • Targeting Zbtb32 presents potential implications for improving cancer immunotherapy strategies.